tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Quoin Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsQuoin Pharmaceuticals Reports Q2 2025 Financial Results
22d ago
Quoin Pharmaceuticals reports Q2 EPS ($6.28) vs ($13.68) last year
Premium
The Fly
Quoin Pharmaceuticals reports Q2 EPS ($6.28) vs ($13.68) last year
23d ago
Buy Rating for Quoin Pharmaceuticals: Promising Developments in Netherton Syndrome Treatment and Strategic Regulatory Advantages
Premium
Ratings
Buy Rating for Quoin Pharmaceuticals: Promising Developments in Netherton Syndrome Treatment and Strategic Regulatory Advantages
29d ago
Quoin Pharmaceuticals announces FDA granted RPD designation for QRX003
PremiumThe FlyQuoin Pharmaceuticals announces FDA granted RPD designation for QRX003
2M ago
Quoin Pharmaceuticals Updates Shareholder Proposal Deadlines
Premium
Company Announcements
Quoin Pharmaceuticals Updates Shareholder Proposal Deadlines
2M ago
Quoin Pharmaceuticals Approves Executive Cash Bonuses
Premium
Company Announcements
Quoin Pharmaceuticals Approves Executive Cash Bonuses
3M ago
Quoin Pharmaceuticals Reports Q1 2025 Progress and Financials
PremiumCompany AnnouncementsQuoin Pharmaceuticals Reports Q1 2025 Progress and Financials
4M ago
Quoin Pharmaceuticals Ltd – ADR trading resumes
Premium
The Fly
Quoin Pharmaceuticals Ltd – ADR trading resumes
4M ago
Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause
Premium
The Fly
Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100